Cressey, Tim R.
Siriprakaisil, Oraphan
Klinbuayaem, Virat
Quame-Amaglo, Justice
Kubiak, Rachel W.
Sukrakanchana, Pra-ornsuda
Than-in-at, Kanchana
Baeten, Jared
Sirirungsi, Wasna
Cressey, Ratchada
Drain, Paul K.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R21AI127200-01)
Article History
Received: 17 June 2017
Accepted: 4 July 2017
First Online: 14 July 2017
Ethics approval and consent to participate
: The study protocol and consent documents have been approved by Ethics Committees at the Institute for the Development of Human Research Protections at the Medical Sciences Department, Thai Ministry of Public Health; Sanpatong Hospital; Faculty of Associated Medical Sciences at Chiang Mai University, and the University of Washington Institutional Review Board in Seattle.
: Not applicable.
: JB has served on an advisory board for Gilead Sciences Inc. and has previously received medications from Gilead Sciences to support the conducted of PrEP for HIV prevention studies. The other authors declare that they have no competing interests.